R

Avidity Biosciences Inc.
D

RNAM

72.920
USD
0.13
(0.17%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-17
حجم السوق
11,313,512,186
المقالات

العنوان: Avidity Biosciences Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. The company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.